Skip to content

C84.70

Billable

Anaplastic large cell lymphoma, ALK-negative, unspecified site

HCC Category Mapping

V28HCC 19Lymphoma and Other Cancers
0.105
V24HCC 10Lymphoma and Other Cancers
0.675
ESRDHCC 10Lymphoma and Other Cancers
0.000
RxHCCHCC 21Hodgkin Lymphoma and Other Cancers
0.000

What This Code Means

A type of aggressive lymphoma (cancer of immune cells) that lacks a specific genetic marker (ALK-negative) and the exact location of the cancer is not specified.

Coding Tips

  • This is an unspecified site code; attempt to obtain more specific anatomical location from the pathology report or clinical documentation
  • ALK-negative status should be confirmed through immunohistochemistry or molecular testing documented in the medical record

Clinical Significance

Anaplastic large cell lymphoma, ALK-negative, unspecified site is an aggressive T-cell lymphoma lacking the ALK fusion protein. ALK-negative ALCL has a significantly worse prognosis than ALK-positive disease, with 5-year survival rates of approximately 40-50%. This distinction is critical because it affects treatment decisions and clinical trial eligibility. The unspecified site indicates the anatomical location was not documented.

Documentation Requirements

  • Pathology confirming ALCL with hallmark cells and CD30 positivity
  • ALK-negative status confirmed by immunohistochemistry or molecular testing
  • T-cell immunophenotype confirmed
  • Clinical staging documentation
  • Provider should be queried for specific site of involvement to enable more specific coding

Commonly Confused Codes

Code Hierarchy

Open C84.70 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.